Robert J. Hombach
Independent DirectorMr. Robert J. Hombach, also known as Bob, is Director of 4D Path, Inc. from May 2026. Mr. Hombach is an Independent Non-Employee Director of Seaport Therapeutics, Inc. from March 2025. Mr. Hombach was Independent Director of Henry Schein, Inc. from January 27, 2025 until May 21, 2026. Mr. Hombach is an Independent Director at Embecta Corp since March 20, 2022. He had been Director of Aptinyx Inc. since May 17, 2018 until June 30, 2023. Mr. Hombach served as the Chief Financial Officer, Chief Operations Officer and Executive Vice President at Baxalta Incorporated from July 2015 until the acquisition of Baxalta by Shire plc in June 2016. He has over many years of financial and operational leadership experience in the healthcare sector. Mr. Hombach served the Chief Financial Officer and Corporate Vice President of Baxter International Inc. from June 2010 to July 1, 2015 and from February 13, 2007 to July 1, 2015, respectively. Mr. Hombach served as Treasurer of Baxter International Inc. from February 13, 2007 to March 2011. He served as Vice President of Finance, Europe, Middle East and Africa at Baxter from 2004 to 2007. Mr. Hombach has served in a number of finance positions with increasing responsibility in the planning, manufacturing, operations and treasury areas since joining Baxter in 1989. He has been a Director of Synovis Life Technologies Inc since February 14, 2012. He serves as an Independent Director of BioMarin Pharmaceutical Inc. since October 2017. He had been an Independent Director of CarMax Inc. since April 1, 2018 until June 28, 2022. He served as a Director of Naurex, Inc.since 2012 until 2015. He serves as Director at BCU. He served as a Director of Loyola University Health System. He has served as a Board Member for a number of public, private and not-for-profit companies. He won an Elijah Watt Sells Award on the November 1990 certified public accountant exam and also has earned the certified management accountant designation. Mr. Hombach earned his Master's Degree in Business Administration from Northwestern University's J.L. Kellogg Graduate School of Management and his Bachelor of Science Degree in Finance from University of Colorado at Boulder.
Positions
- Company NameBioMarin Pharmaceutical Inc.Stock CodeBMRNPositionIndependent DirectorColleagues
- AHAlexander HardyPresident, CEO & Director
- ITIan T. ClarkIndependent Chair of the Board
- BRBrian R. MuellerCFO & Executive VP of Finance
- CGC. Greg GuyerExecutive VP & CTO
- CHCristin HubbardExecutive VP & Chief Commercial Officer
- GFGregory FribergExecutive VP and Chief Research & Development Officer
- RJRobert J. HombachIndependent Director
- EMElizabeth McKee AndersonIndependent Director
- MJMark Joseph EnyedyIndependent Director
- Company NameEmbecta Corp.Stock CodeEMBCPositionIndependent DirectorColleagues
- DKDevdatt KurdikarPresident, CEO & Chairman
- JPJacob P. ElguiczeSenior VP & CFO
- JZJeffrey Z. MannSenior VP, General Counsel, Head of Business Development & Corporate Secretary
- JMJean M. CasnerSenior VP & Chief Human Resources Officer
- SCShaun CurtisSenior Vice President of Global Manufacturing & Supply Chain
- RJRobert J. HombachIndependent Director
- CPClaire PomeroyLead Independent Director
- KNKaren N. PrangeIndependent Director
- CRChristopher R. ReidyIndependent Director
- Company NameSeaport Therapeutics, Inc.Stock CodeSPTXPositionIndependent Non-Employee DirectorColleagues
- SMSteven M. PaulFounder & Non-Employee Chair of the Board
- DZDaphne ZoharFounder, CEO, President & Director
- MCMichael Cunyuan ChenCo-Founder & Chief Scientific Officer
- ALAntony LoebelChief Medical Officer & President of Clinical Development
- LALauren A. WhiteChief Financial Officer
- DMDenice M. TorresLead Independent Non-Employee Director
- SESandra E. PetersonIndependent Non-Employee Director
